A Study Investigating the Safety and Performance of DV3395, a New Concept Device for the Delivery of Medicine.

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

November 8, 2022

Study Completion Date

November 8, 2022

Conditions
Healthy Volunteers, Medical Device
Interventions
DEVICE

DV3395 C1

Participants will be exposed to and swallow DV3395 C1 once. The participants will stay at the clinic research center for up to 6 days .

Trial Locations (1)

9728 NZ

ICON - location Groningen, Groningen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY